Palvella Therapeutics, Inc. (PVLA) Financials

PVLA Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 253.5 million 36.6 million
March 31, 2026 263.8 million 31.4 million
Dec. 31, 2025 59.6 million 31.6 million
Sept. 30, 2025 66.9 million 28.3 million

PVLA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -12.8 million 5.2 million
March 31, 2026 -10.9 million 3.4 million
Dec. 31, 2025 -4.9 million 1.1 million
Sept. 30, 2025 -7.9 million 1.8 million

PVLA Net Income

No data available :(

PVLA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 250.6 million - 535000
March 31, 2026 261.9 million 375000 209000
Dec. 31, 2025 58.0 million 431000 202000
Sept. 30, 2025 63.6 million 16.0 million -

PVLA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 14.4 million
March 31, 2026 13.1 million
Dec. 31, 2025 11.3 million
Sept. 30, 2025 11.1 million

PVLA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 12.5 million 8.9 million -
March 31, 2026 - 9.3 million 5.5 million -
Dec. 31, 2025 - 7.1 million 4.2 million -
Sept. 30, 2025 - 6.5 million 3.6 million -

PVLA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - -
Dec. 31, 2025 - -
Sept. 30, 2025 - -

PVLA

Price: $140.69

52 week price:
37.33
161.38

Earnings Per Share: -4.69 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 2.2 billion

Links: